Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 5,923 | 5,820 | 6,029 | 6,360 | 3,800 |
| Operating Income | -5,923 | -5,820 | -6,029 | -6,360 | -3,800 |
| Other Income | 5 | 1 | 1 | 2 | 184 |
| Pre-tax Income | -5,918 | -5,819 | -6,028 | -6,357 | -3,615 |
| Net Income Continuous | -5,918 | -5,819 | -6,028 | -6,357 | -3,615 |
| Net Income | $-5,918 | $-5,819 | $-6,028 | $-6,357 | $-3,615 |
| EPS Basic Total Ops | -28.23 | -29.13 | -34.23 | -39.04 | 21.02 |
| EPS Basic Continuous Ops | -27.33 | -29.19 | -34.31 | -39.66 | 21.02 |
| EPS Diluted Total Ops | -28.23 | -29.13 | -34.23 | -39.04 | 21.02 |
| EPS Diluted Continuous Ops | -27.33 | -29.19 | -34.31 | -39.66 | 21.02 |
| EBITDA(a) | $-5,884 | $-5,783 | $-5,990 | $-6,324 | $-3,764 |